Which patents are listed for Ozempic in the FDA Orange Book?
Ozempic (semaglutide) is listed in the FDA’s Orange Book for products with approved drug applications, including associated patents and exclusivities. To see the exact Orange Book patent numbers, expiration dates, and exclusivity windows for Ozempic, you can search the Orange Book directly and open the Ozempic entry to view the “Patent Information” section.
Because patent listings are updated over time (newly listed patents, expiration changes, or additional listed exclusivities), the most reliable way to confirm the current Orange Book details for Ozempic is to use the FDA Orange Book search tool.
How can I check Ozempic Orange Book “patent expiry” and “exclusivity” dates?
When you open Ozempic’s record in the Orange Book, you’ll typically see multiple time-related items that can include:
- Patent expiration dates (for specific listed patents)
- Exclusivity information (for example, application-specific periods of market exclusivity)
Search users often want the earliest date when an ANDA or similar generic application could potentially enter. That “earliest entry” can depend on which specific patent(s) and exclusivity periods block approval for the exact Ozempic dosage form and strength.
Why do multiple Orange Book patents show for the same drug?
A single branded drug can have many listed patents covering different aspects, such as:
- The active ingredient (or related compound claims)
- Formulation (how the drug is made)
- Methods of use (how it’s used in treatment)
That means generics or biosimilar candidates may need to address (or “carve out”) specific patents that are still listed and not expired for the relevant product.
Are Ozempic Orange Book patents challenged with ANDA litigation?
Patent challenges tied to Orange Book listings are common in the U.S. generic pathway and often drive litigation around when a generic can launch. If you’re trying to understand the real-world impact of Ozempic’s Orange Book listings, litigation trackers can help map which patents are being asserted and against which generic filers.
For a consolidated view of Ozempic-related patent activity and reported patent status, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/ (search for Ozempic/semaglutide).
Do patent dates differ by Ozempic strength or formulation?
Yes. Ozempic comes in multiple strengths and has multiple presentations (depending on the approved product listing). Orange Book entries are specific, so the listed patents and the relevant “expiration” or “blocking” dates can differ between product entries.
If you want, tell me which Ozempic entry you mean (for example, the exact strength/form), and I can help you interpret how to read the Orange Book fields for that specific record.
Where to find the FDA Orange Book entry for Ozempic?
Use the FDA Orange Book database and search by:
- “Ozempic”
- or the active ingredient “semaglutide”
Then open the specific product listing to view the “Patent Information” section and the exclusivity details.
---
Sources
- DrugPatentWatch.com